10-69844853-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001368882.1(COL13A1):​c.364+22415A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.806 in 152,224 control chromosomes in the GnomAD database, including 50,018 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.81 ( 50018 hom., cov: 34)

Consequence

COL13A1
NM_001368882.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.130

Publications

1 publications found
Variant links:
Genes affected
COL13A1 (HGNC:2190): (collagen type XIII alpha 1 chain) This gene encodes the alpha chain of one of the nonfibrillar collagens. The function of this gene product is not known, however, it has been detected at low levels in all connective tissue-producing cells so it may serve a general function in connective tissues. Unlike most of the collagens, which are secreted into the extracellular matrix, collagen XIII contains a transmembrane domain and the protein has been localized to the plasma membrane. The transcripts for this gene undergo complex and extensive splicing involving at least eight exons. Like other collagens, collagen XIII is a trimer; it is not known whether this trimer is composed of one or more than one alpha chain isomer. A number of alternatively spliced transcript variants have been described, but the full length nature of some of them has not been determined. [provided by RefSeq, Jul 2008]
COL13A1 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 19
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001368882.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL13A1
NM_001368882.1
MANE Select
c.364+22415A>G
intron
N/ANP_001355811.1
COL13A1
NM_001130103.2
c.364+22415A>G
intron
N/ANP_001123575.1
COL13A1
NM_080801.4
c.364+22415A>G
intron
N/ANP_542991.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL13A1
ENST00000645393.2
MANE Select
c.364+22415A>G
intron
N/AENSP00000496051.1
COL13A1
ENST00000398978.8
TSL:5
c.364+22415A>G
intron
N/AENSP00000381949.3
COL13A1
ENST00000354547.7
TSL:5
c.364+22415A>G
intron
N/AENSP00000346553.3

Frequencies

GnomAD3 genomes
AF:
0.806
AC:
122591
AN:
152106
Hom.:
49988
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.675
Gnomad AMI
AF:
0.805
Gnomad AMR
AF:
0.778
Gnomad ASJ
AF:
0.825
Gnomad EAS
AF:
0.856
Gnomad SAS
AF:
0.935
Gnomad FIN
AF:
0.861
Gnomad MID
AF:
0.822
Gnomad NFE
AF:
0.869
Gnomad OTH
AF:
0.809
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.806
AC:
122675
AN:
152224
Hom.:
50018
Cov.:
34
AF XY:
0.810
AC XY:
60285
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.675
AC:
28049
AN:
41528
American (AMR)
AF:
0.777
AC:
11897
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.825
AC:
2866
AN:
3472
East Asian (EAS)
AF:
0.856
AC:
4421
AN:
5162
South Asian (SAS)
AF:
0.936
AC:
4513
AN:
4824
European-Finnish (FIN)
AF:
0.861
AC:
9128
AN:
10606
Middle Eastern (MID)
AF:
0.822
AC:
240
AN:
292
European-Non Finnish (NFE)
AF:
0.869
AC:
59115
AN:
68018
Other (OTH)
AF:
0.812
AC:
1713
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1205
2410
3614
4819
6024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.775
Hom.:
17959
Bravo
AF:
0.788
Asia WGS
AF:
0.869
AC:
3022
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
1.6
DANN
Benign
0.55
PhyloP100
-0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2704482; hg19: chr10-71604609; API